新開普(300248.SZ):已爲近40所院校、企業建設了數字人民幣項目
格隆匯6月17日丨新開普(300248.SZ)在投資者互動平臺表示,公司的數字人民幣項目主要是爲校園、政企、公交等領域提供支付平臺和收款設備的整體解決方案,已爲近40所院校、企業建設了數字人民幣項目,並與中國人民銀行數字貨幣研究所、六大行(中行、農行、工行、建行、交行、郵儲)、三大運營商(移動、電信、 聯通)建立了長期穩定的合作關係。公司碼卡臉一校通系統深度融合智慧校園生態,基於物聯網與人工智能技術,整合人臉、掌紋、二維碼、CPU卡等多種介質,廣泛應用於身份覈驗、便捷支付、出入管理等場景,爲用戶提供高效、安全、無感的核身體驗和“一卡/碼通行、一賬通付”的便捷服務。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.